Comparing Glycemic Control of Children and Adolescents with Type 1 Diabetes on Multiple Daily Insulin Injection and those on Insulin Pump Therapy in limited resource Settings

Authors

  • Shereen Abdelghaffar
  • Marise Antoun Fahmy Abdou
  • Samar Mohamad Elsayed Elnemr
  • Radwa Shamma

Keywords:

Glycemic Control, Type 1 Diabetes, Multiple Daily Insulin Injection, Insulin Pump Therapy

Abstract

Background: Type 1 diabetes (T1D) is one of the most common chronic diseases in children. Overall, approximately 96,000 children under 15 years are estimated to develop type 1 diabetes annually worldwide.

Aim of the work: To compare glycemic control of patients with (T1D) treated with different modalities, multiple daily injection (MDI) and continuous subcutaneous insulin infusion (CSII).

Patients and Methods: This cross-sectional study was conducted on 30 patients diagnosed with T1D following at Diabetes & Endocrine Pediatric unit at Galaa Military hospital, patients were divided into two equal groups, group (A) 15 patients on MDI, group (B) 15 patients on CSII MiniMed paradigm 715 version. Not all patients were using continuous glucose monitoring (CGM), only 2 patients used flash glucose monitoring. Demographics, clinical data, and investigations were done with special emphasis on HbA1c at the beginning of the study, at three and six months. 

Results: The average blood glucose checks/day were significantly higher in patients on MDI (8.47 ± 1.68) than patients on pump (7.00 ± 1.36) with p-value = 0.014. There was statistically significant decrease in HbA1c level in patients on MDI after 6 months of glycemic control compared to that at the start of study and at 3 months with p-value < 0.001. However, there was a statistically significant increase in HbA1c level in patients on CSII after 6 months compared to that at start and at 3 months of the study with p-value < 0.001

Conclusion: Our study found no significant overall differences in glycemic control in the form of HbA1c between CSII and MDI therapy for children with T1D. It's clear that a pump with CGM will give the best glycemic index & more physiological treatment while a pump without CGM can give a false sense of security resulting in complications. So, for limited resource countries, CGM with MDI will be preferable over pump insertion without CGM

Downloads

Download data is not yet available.

References

Magliano DJ, Boyko EJ; IDF Diabetes Atlas 10th edition scientific committee. IDF DIABETES ATLAS [Internet]. 10th edition. Brussels: International Diabetes Federation; 2021. Chapter 3, Global picture. Available from: https://www.ncbi.nlm.nih.gov/books/NBK581940/

Šumnik Z, Pavlíková M, Neuman V, et al. Glycemic Control by Treatment Modalities: National Registry-Based Population Data in Children and Adolescents with Type 1 Diabetes. Horm Res Paediatr. 2024;97(1):70-79. doi: 10.1159/000530833. Epub 2023 Apr 26. PMID: 37100041.

Tremamunno S, Tartaglione L, Telesca A, et al. Insulin pump treatment vs. multiple daily insulin injections in patients with poorly controlled Type 2 diabetes mellitus: a comparison of cardiovascular effects. Endocrine. 2024 Apr;84(1):128-135. doi: 10.1007/s12020-023-03651-w. Epub 2024 Jan 10. PMID: 38197988; PMCID: PMC10987338.

Powers AC. Type 1 diabetes mellitus: much progress, many opportunities. J Clin Invest. 2021 Apr 15;131(8): e142242. doi: 10.1172/JCI142242. PMID: 33759815; PMCID: PMC8262558.

Babiker A, Alammari N, Aljuraisi A, et al. The Effectiveness of Insulin Pump Therapy Versus Multiple Daily Injections in Children with Type 1 Diabetes Mellitus in a Specialized Center in Riyadh. Clin Med Insights Endocrinol Diabetes. 2022 Oct 20; 15:11795514221128495. doi: 10.1177/11795514221128495. PMID: 36313241; PMCID: PMC9597023.

Moser EG, Morris AA, Garg SK. Emerging diabetes therapies and technologies. Diabetes Res Clin Pract. 2012 Jul;97(1):16-26. doi: 10.1016/j.diabres.2012.01.027. Epub 2012 Feb 29. PMID: 22381908.

Karges B, Schwandt A, Heidtmann B, et al. Association of Insulin Pump Therapy vs Insulin Injection Therapy with Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults with Type 1 Diabetes. JAMA. 2017 Oct 10;318(14):1358-1366. doi: 10.1001/jama.2017.13994. PMID: 29049584; PMCID: PMC5818842.

AbdulRasoul MM, Mousa M, Al-Mahdi M, et al. A Comparison of Continuous Subcutaneous Insulin Infusion vs. Multiple Daily Insulin Injection in Children with Type I Diabetes in Kuwait: Glycemic Control, Insulin Requirement, and BMI. Oman Med J. 2015 Sep;30(5):336-43. doi: 10.5001/omj.2015.69. PMID: 26421114; PMCID: PMC4576387.

Ribeiro ME, Del Roio Liberatore Junior R, Custodio R, et al. Insulinoterapia contínua versus múltiplas injeções de insulina no tratamento da diabetes tipo 1: um estudo longitudinal [Continuous insulin therapy versus multiple insulin injections in the management of type 1 diabetes: a longitutinal study]. Rev Paul Pediatr. 2016 Jan-Mar;34(1):86-90. doi: 10.1016/j.rpped.2015.06.011. Epub 2016 Jan 13. PMID: 26826879; PMCID: PMC4795726.

Downloads

Published

2025-05-22

How to Cite

1.
Abdelghaffar S, Fahmy Abdou MA, Elsayed Elnemr SM, Shamma R. Comparing Glycemic Control of Children and Adolescents with Type 1 Diabetes on Multiple Daily Insulin Injection and those on Insulin Pump Therapy in limited resource Settings. J Neonatal Surg [Internet]. 2025May22 [cited 2025Sep.30];14(26S):495-500. Available from: https://www.jneonatalsurg.com/index.php/jns/article/view/6315